Financing Agreements in the Health Care Technology Industry
14 Contracts & Agreements
- Avant Diagnostics, Inc (5 contracts)
- Health Catalyst, Inc. (1)
- NATURAL HEALTH FARM HOLDINGS INC (1)
- OptimizeRx Corp (2)
- True Nature Holding, Inc. (5)
- Form of financing agreement (True Nature Holding, Inc., Filed With SEC on September 10, 2024)
- Form of financing agreement (True Nature Holding, Inc., Filed With SEC on August 27, 2024)
- Form of financing agreement (True Nature Holding, Inc., Filed With SEC on July 19, 2024)
- Form of Financing Agreement (True Nature Holding, Inc., Filed With SEC on May 16, 2024)
- Amendment No. 1 to Financing Agreement, dated March 29, 2024 (OptimizeRx Corp, Filed With SEC on April 2, 2024)
- Financing Agreement, dated as of October 11, 2023, by and among OptimizeRx Corporation, the lenders from time to time party thereto, and Blue Torch Finance, LLC, as collateral... (OptimizeRx Corp, Filed With SEC on October 16, 2023)
- Amendment No. 1 to Financing Documents, dated July 10, 2019, by and among the Registrant and certain of its stockholders (Health Catalyst, Inc., Filed With SEC on July 12, 2019)
- Form of Subscription Agreement for the Series C Financing (Avant Diagnostics, Inc, Filed With SEC on August 28, 2018)
- Equity Financing Agreement dated July 20, 2018 with GHS Investments, LLC (True Nature Holding, Inc., Filed With SEC on August 16, 2018)
- Equity Financing Agreement dated June 5, 2018 with GHS Investments, LLC (NATURAL HEALTH FARM HOLDINGS INC, Filed With SEC on June 11, 2018)
- Form of Subscription Agreement for the May 2018 Financing (Avant Diagnostics, Inc, Filed With SEC on May 25, 2018)
- Form of Pledge Agreement by and between Avant Diagnostics, Inc. and the June 2017 Investor related to the June 2017 and August 2017 Financing (Avant Diagnostics, Inc, Filed With SEC on September 26, 2017)
- Form of Right related to the related to the June 2017 and August 2017 Financing with the June 2017 Investor (Avant Diagnostics, Inc, Filed With SEC on September 26, 2017)
- Form of Right related to the June 2017 Financing (Avant Diagnostics, Inc, Filed With SEC on June 21, 2017)
